FibroGen Inc - Company Profile
Powered by
All the data and insights you need on FibroGen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date FibroGen Inc Strategy Report
- Understand FibroGen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on FibroGen Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
19 Jul 2021 | Eluminex Biosciences Enters into Licensing Agreement with FibroGen | Licensing Agreement |
Eluminex Biosciences Ltd
|
FibroGen Inc |
17 Jun 2021 | FibroGen Exercises License Option from HiFiBiO | Licensing Agreement |
FibroGen Inc
|
HiFiBiO Therapeutics
|
09 Nov 2020 | FibroGen Enters Manufacturing Agreement with Samsung Biologics for Pamrevlumab | Contract Service Agreement |
FibroGen Inc
|
Samsung Biologics Co Ltd |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer